According to CuraGen founder and CEO Jonathan Rothberg, 454's goals are very different than its parent: Whereas CuraGen is focused on drug development, 454's focus will be on creating tools ...

Necessity is often credited as the mother of invention. For Jonathan Rothberg it was the frustration of sitting around in hospital waiting rooms that made him the father of a new idea. His ...

J. Craig Venter plans to develop a machine to find and sequence DNA on Mars, but another genomics mogul, Jonathan Rothberg, may beat him to it. Jef Akst was managing editor of The Scientist, where she ...